Tag Archives: vaccine development
Abrysvo RSV Vaccine Shows Promise for At-Risk Adults: Phase 3 Trial Results
Pfizer's Abrysvo RSV vaccine shows promise in a phase 3 trial for at-risk adults aged.....Read more
05
Dec
Dec
Unmet Needs in RSV Prevention and Management
RSV prevention and management face ongoing challenges, especially for infants lacking accessible preventative options. Continued.....Read more
05
Dec
Dec
RSV: New Tools and Treatments Offer Hope in Europe
Respiratory syncytial virus (RSV) poses a significant health threat, particularly to vulnerable populations. Recent advancements.....Read more
29
Nov
Nov